Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Goodwill (2021 - 2025)

Historic Goodwill for Strata Critical Medical (SRTA) over the last 5 years, with Q3 2025 value amounting to $84.6 million.

  • Strata Critical Medical's Goodwill rose 9698.04% to $84.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.6 million, marking a year-over-year increase of 9698.04%. This contributed to the annual value of $15.5 million for FY2024, which is 6150.89% down from last year.
  • Strata Critical Medical's Goodwill amounted to $84.6 million in Q3 2025, which was up 9698.04% from $44.3 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Goodwill ranged from a high of $84.6 million in Q3 2025 and a low of $13.3 million during Q3 2021
  • Moreover, its 5-year median value for Goodwill was $39.6 million (2024), whereas its average is $34.9 million.
  • As far as peak fluctuations go, Strata Critical Medical's Goodwill soared by 19929.47% in 2023, and later tumbled by 6150.89% in 2024.
  • Strata Critical Medical's Goodwill (Quarter) stood at $13.3 million in 2021, then skyrocketed by 195.96% to $39.4 million in 2022, then increased by 2.35% to $40.4 million in 2023, then tumbled by 61.51% to $15.5 million in 2024, then soared by 444.45% to $84.6 million in 2025.
  • Its Goodwill stands at $84.6 million for Q3 2025, versus $44.3 million for Q2 2025 and $42.0 million for Q1 2025.